Karklinsh Robert – Trademark Portfolio
Entity Type: 01
Karklinsh Robert holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 6 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELSTM and ELASTIUM. The owner is based in Los Angeles, CA.
4850 Hollywood Blvd
Los Angeles, CA 90027
Showing of trademarks Trademarks
Trademark Classifications
Karklinsh Robert's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Machines and machine tools; motors and engines; machine coupling and transmission components
Frequently Asked Questions
How many trademarks does Karklinsh Robert have?
Karklinsh Robert has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Karklinsh Robert file in?
Karklinsh Robert files trademarks across 6 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 7 (Machinery). Class 25 covers clothing, footwear, headgear.
What are Karklinsh Robert's most well-known trademarks?
Karklinsh Robert's registered trademark portfolio includes well-known marks such as ELSTM and ELASTIUM. These are among 2 currently registered trademarks in the portfolio.
What is Karklinsh Robert's trademark registration success rate?
Karklinsh Robert has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.